<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
62938-0029-1
</NDCCode>
<PackageDescription>
630 BLISTER PACK in 1 BOX (62938-0029-1) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
</PackageDescription>
<NDC11Code>
62938-0029-01
</NDC11Code>
<ProductNDC>
62938-0029
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Selegiline Hydrochloride
</NonProprietaryName>
<DosageFormName>
TABLET, ORALLY DISINTEGRATING
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20060614
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
CATALENT U.K. SWINDON ZYDIS LIMITED
</LabelerName>
<SubstanceName>
SELEGILINE HYDROCHLORIDE
</SubstanceName>
<StrengthNumber>
1.25
</StrengthNumber>
<StrengthUnit>
mg/1
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2025-11-24
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
14-JUN-06
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>